These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 7811529

  • 21. [Bacteriological monitoring of the treatment of Pseudomonas aeruginosa infections with amikacin administrated at once-daily dosis in patients with cystic fibrosis].
    Canis F, Husson MO, Vic P, Ategbo S, Turck D, Courcol R, Leclerc H.
    Pathol Biol (Paris); 1995 Apr; 43(4):343-51. PubMed ID: 7567127
    [Abstract] [Full Text] [Related]

  • 22. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
    Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H.
    Scand J Infect Dis; 2008 Apr; 40(6-7):487-94. PubMed ID: 18584536
    [Abstract] [Full Text] [Related]

  • 23. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S, Morrissey JP, O'Gara F, Boyd EF.
    J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
    [Abstract] [Full Text] [Related]

  • 24. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M.
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [Abstract] [Full Text] [Related]

  • 25. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.
    Anuj SN, Whiley DM, Kidd TJ, Ramsay KA, Bell SC, Syrmis MW, Grimwood K, Wainwright CE, Nissen MD, Sloots TP.
    Clin Microbiol Infect; 2011 Sep; 17(9):1403-8. PubMed ID: 21129101
    [Abstract] [Full Text] [Related]

  • 26. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H, Ongen B, Erturan Z, Salcioğlu M.
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [Abstract] [Full Text] [Related]

  • 27. Application and evaluation of double digest selective label (DDSL) typing technique for Pseudomonas aeruginosa hospital isolates.
    Terletskiy V, Kuhn G, Francioli P, Blanc DS.
    J Microbiol Methods; 2008 Mar; 72(3):283-7. PubMed ID: 18234379
    [Abstract] [Full Text] [Related]

  • 28. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW.
    J Infect Dis; 2001 Feb 01; 183(3):444-52. PubMed ID: 11133376
    [Abstract] [Full Text] [Related]

  • 29. [Pseudomonas aeruginosa infection in cystic fibrosis: predominance of a single strain and the influence of antibiotic therapy and the environment].
    Michel-Briand Y, Plesiat P, Godard C, Noir A, Estavoyer JM.
    Bull Acad Natl Med; 1992 Nov 01; 176(8):1159-69; discussion 1170-1. PubMed ID: 1300222
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies.
    Ojeniyi B, Lam JS, Høiby N, Rosdahl VT.
    APMIS; 1989 Jul 01; 97(7):631-6. PubMed ID: 2502162
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Giordano A, Magni A, Graziani C, Sessa R, Quattrucci S, Cipriani P.
    New Microbiol; 2001 Apr 01; 24(2):157-63. PubMed ID: 11346299
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug 01; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 37. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F.
    Pediatr Pulmonol; 2009 Aug 01; 44(8):820-5. PubMed ID: 19598278
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov 01; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 40. Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.
    Bergan T, Hoiby N.
    Acta Pathol Microbiol Scand Suppl; 1975 Dec 01; 83(6):553-60. PubMed ID: 812335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.